Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v9-EN
Language English English
Date Updated 2020-02-07 2020-02-07
Drug Identification Number 00502790 00502790
Brand name COTAZYM ECS 8 COTAZYM ECS 8
Common or Proper name PANCRELIPASE DELAYED-RELEASE CAPSULES PANCRELIPASE DELAYED-RELEASE CAPSULES
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients AMYLASE PROTEASE LIPASE AMYLASE PROTEASE LIPASE
Strength(s) 42000UNIT 45000UNIT 10800UNIT 42000UNIT 45000UNIT 10800UNIT
Dosage form(s) CAPSULE (DELAYED RELEASE) CAPSULE (DELAYED RELEASE)
Route of administration ORAL ORAL
Packaging size 500CAP 500CAP
ATC code A09AA A09AA
ATC description DIGESTIVES, INCL ENZYMES DIGESTIVES, INCL ENZYMES
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2020-01-06 2020-01-06
Actual start date 2020-01-02 2020-01-02
Estimated end date 2020-02-14 2020-02-14
Actual end date 2020-02-06 2020-02-06
Shortage status Resolved Resolved
Company comments
Health Canada comments